Synthego
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3696 Haven Ave Ste A, Redwood City, Cali...Phone Number
(844) 427-4777Website
www.synthego.comRevenue
$42.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Synthego
Synthego is a biotechnology company that develops and manufactures CRISPR gene editing reagents, engineered nucleases, GMP guide RNAs, and molecular biology products. The company supports research, cell and gene therapy, and molecular diagnostics workflows with scalable solutions designed to improve precision, quality, and development speed.Explore more
Synthego Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synthego your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Synthego has new funding data
Congratulate Masked Content for being promoted to Masked Content at Synthego
Website visits: Recent activity has been detected on your website
Synthego, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Synthego had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Synthego is spiking on competitors!
Earning: See what the market has to say on Synthego recently announced quarterly report
Check if Synthego has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Synthego launches new products
Recommended Actions
Reach out to Masked Content who joined Synthego as Masked Content
Find more new buyers
Compare Similar Companies to Synthego
Compare insights from companies similar to Synthego, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Synthego is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Synthego is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Synthego.
Synthego financials insights
Gather financial insights about Synthego, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$8.3M
2016
Series A
$8.3M
2017
Series B
$41M
2018
Series C
$110M
2020
Series D
$100M
2022
Series E
$200M
Synthego Tech Stack
A closer look at the technologies used by Synthego
See more technologies
Most Recent Scoops
Hiring Plans
Synthego has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Best Practice Implementation.
Hiring Plans
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Open Position
Hiring Plans
Synthego has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Synthego News & Media
Synthego Announces Entry into Molecular Biology and Clinical Diagnostic Reagents Market
Company Expands Its Innovative Portfolio to Accelerate Advances in Diagnostics REDWOOD CITY, Calif., Jan. 13, 2026 /PRNewswire/ -- Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building upon its...Synthego Announces Successful Close of Acquisition by Perceptive Advisors
/PRNewswire/ -- Synthego, a leading provider of CRISPR solutions, today announced the successful closing of the acquisition of substantially all of its assets...Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July
Synthego Solidly Positioned for Expansion & Growth REDWOOD CITY, Calif., June 26, 2025 /PRNewswire/ -- Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is...Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
REDWOOD CITY, Calif., June 12, 2025 /PRNewswire/ -- Synthego, a pioneering CRISPR Solutions provider, is pleased to announce that the US Court of Appeals for the Federal Circuit has upheld an earlier ruling invalidating patents held by Agilent Technologies, Inc. See the ruling here. In...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synthego
Sign Up For FreeTo access detailed company insights
Synthego is a biotechnology company that develops and manufactures CRISPR gene editing reagents, engineered nucleases, GMP guide RNAs, and molecular biology products. The company supports research, cell and gene therapy, and molecular diagnostics workflows with scalable solutions designed to improve precision, quality, and development speed.... Read More
